These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28453459)

  • 41. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
    Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
    Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate.
    Lim E; Belcher E; Yap YK; Nicholson AG; Goldstraw P
    J Thorac Oncol; 2008 Nov; 3(11):1267-71. PubMed ID: 18978561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of surgery in small cell lung cancer].
    Bolca C; Dănăilă O; Paleru C; Cordoş I
    Pneumologia; 2013; 62(4):236-8. PubMed ID: 24734358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
    Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
    J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.
    Yu JB; Decker RH; Detterbeck FC; Wilson LD
    J Thorac Oncol; 2010 Feb; 5(2):215-9. PubMed ID: 20101146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004.
    Takei H; Kondo H; Miyaoka E; Asamura H; Yoshino I; Date H; Okumura M; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Dosaka-Akita H; Kobayashi H; Sawabata N; Yokoi K;
    J Thorac Oncol; 2014 Aug; 9(8):1140-5. PubMed ID: 25157766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J; Pang QS; Wang P; Wang J; Wang W
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base.
    Combs SE; Hancock JG; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Thorac Oncol; 2015 Feb; 10(2):316-23. PubMed ID: 25319182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
    Sas-Korczynska B; Sokolowski A; Korzeniowski S
    Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
    Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. When is surgery indicated for small-cell lung cancer?
    Veronesi G; Bottoni E; Finocchiaro G; Alloisio M
    Lung Cancer; 2015 Dec; 90(3):582-9. PubMed ID: 26520187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 20-year retrospective study of small-cell carcinomas in Taiwan.
    Li AF; Hsu HS; Hsu CY; Li AC; Li WY; Liang WY; Chen JY
    J Surg Oncol; 2010 Oct; 102(5):497-502. PubMed ID: 20872953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer.
    Almquist D; Mosalpuria K; Ganti AK
    J Oncol Pract; 2016 Feb; 12(2):111-7. PubMed ID: 26869647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
    Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.